BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1768057)

  • 1. Effects of L-histidinol on the proliferation and anticancer drug susceptibility of cultured B16f10 melanoma cells.
    Warrington RC; Cheng I; Fang W
    Anticancer Res; 1991; 11(5):1863-7. PubMed ID: 1768057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-histidinol increases the vulnerability of cultured human leukemia and lymphoma cells to anticancer drugs.
    Warrington RC; Cheng I; Zhang L; Fang WD
    Anticancer Res; 1993; 13(6A):2107-12. PubMed ID: 8297120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-histidinol protection against cytotoxic action of cytosine arabinoside and 5-fluorouracil in cultured mouse spleen cells.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1982 Feb; 68(2):279-86. PubMed ID: 6950159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice.
    Warrington RC; Cheng I; Fang WD
    J Natl Cancer Inst; 1987 Jun; 78(6):1177-83. PubMed ID: 3108563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved treatment of disseminated B16f10 melanoma in mice with anticancer drugs in combination with L-histidinol.
    Warrington RC; Fang WD
    Anticancer Res; 1991; 11(5):1869-74. PubMed ID: 1722659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of L-histidinol and homoharringtonine on 5-fluorouracil and bis-chloroethylnitrosourea activity in a murine model.
    Warrington RC; Fang WD
    Anticancer Res; 1991; 11(5):1879-83. PubMed ID: 1768059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of human colon carcinoma cells to anticancer drugs is enhanced by L-histidinol.
    Warrington RC; Cheng I; Fang WD
    Anticancer Res; 1994; 14(2A):367-72. PubMed ID: 8017835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1985 May; 74(5):1071-7. PubMed ID: 3858576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
    Warrington RC; Muzyka TG; Fang WD
    Cancer Res; 1984 Jul; 44(7):2929-35. PubMed ID: 6722819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and L-histidinol.
    Warrington RC
    Anticancer Res; 1986; 6(3 Pt B):451-64. PubMed ID: 3090929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity, schedule, and proliferation dependence of infused L-histidinol after 5-fluorouracil in mice.
    Edelstein MB; Heilbrun LK
    Cancer Res; 1988 Mar; 48(6):1470-5. PubMed ID: 3345520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-histidinol selectively modulates daunomycin toxicity in normal and tumorigenic kidney epithelial cells.
    Warrington RC; Fang WD; Zhang L; Shieh M; Saier MH
    Anticancer Res; 1996; 16(6B):3629-33. PubMed ID: 9042233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-histidinol reverses resistance to cisplatinum and other antineoplastics in a tumorigenic epithelial cell line.
    Warrington RC; Fang WD; Zhang LU
    Anticancer Res; 1996; 16(6B):3641-6. PubMed ID: 9042235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple, informative, and quantitative flow cytometric method for assessing apoptosis in cultured cells.
    Warrington RC; Norum JN; Hilchey JL; Watt C; Fang WD
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):231-43. PubMed ID: 12657362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of serum withdrawal on the proliferation of B16F10 melanoma cells.
    Rodriguez-Ayerbe C; Smith-Zubiaga I
    Cell Biol Int; 2000; 24(5):279-83. PubMed ID: 10805961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimetics of L-histidinol which selectively modulate daunomycin toxicity in normal and tumorigenic epithelial cells.
    Warrington RC; Fang WD; Zhang L; Shieh M; Saier MH
    Anticancer Res; 1996; 16(6B):3635-9. PubMed ID: 9042234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective killing of transformed cells by methotrexate with histidine deprivation or with alpha-amino alcohols.
    Newman EM; Nierenberg DW; Santi DV
    Cancer Res; 1983 Oct; 43(10):4703-8. PubMed ID: 6883328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The inhibition of the proliferation and energy metabolism of Cloudman melanoma cells in vitro by aphidicolin and gamma radiation].
    Merte H; Schachtschabel DO; Plamper G; Pfab R
    Strahlenther Onkol; 1994 Jun; 170(6):352-8. PubMed ID: 8023245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.